Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
mi
from
Brooklyn, NY
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Updated: 1/1/1970
New York Methodist Hospital
mi
from
Brooklyn, NY
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
mi
from
Rapid City, SD
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Rapid City, SD
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
mi
from
Chattanooga, TN
Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chattanooga, TN
Supervised Treadmill Exercise And Ranolazine For Intermittent Claudication Of Lower Extremities
Supervised Treadmill Exercise And Ranolazine For Intermittent Claudication Of Lower Extremities. THE STERILE TRIAL.
Status: Archived
mi
from
Royal oak, MI
Supervised Treadmill Exercise And Ranolazine For Intermittent Claudication Of Lower Extremities
Supervised Treadmill Exercise And Ranolazine For Intermittent Claudication Of Lower Extremities. THE STERILE TRIAL.
Status: Archived
Updated: 1/1/1970
Wiiliam Beaumont Hospital
mi
from
Royal oak, MI
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
mi
from
Denver, CO
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Denver, CO
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
mi
from
Centralia, IL
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Centralia, IL
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
mi
from
Bettendorf, IA
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Bettendorf, IA
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
mi
from
Louisville, KY
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Louisville, KY
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
mi
from
Jackson, MS
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Jackson, MS
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
mi
from
St Louis, MO
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
St Louis, MO
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
mi
from
Albany, NY
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Albany, NY
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
mi
from
Charlotte, NC
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Charlotte, NC
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
mi
from
Lima, OH
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Lima, OH
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
mi
from
Medford, OR
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Medford, OR
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
mi
from
Nashville, TN
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Nashville, TN
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
mi
from
Austin, TX
Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
CRYptogenic STroke And underLying AF Trial
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
Vascular Inflammation in Adolescents With Type 1 Diabetes
Prevalence of Oxidative Stress, Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness (cIMT) and Biomarkers of Vascular Inflammation in Adolescents With Type-1 Diabetes Mellitus (T1DM)
Status: Archived
mi
from
Kansas City, MO
Vascular Inflammation in Adolescents With Type 1 Diabetes
Prevalence of Oxidative Stress, Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness (cIMT) and Biomarkers of Vascular Inflammation in Adolescents With Type-1 Diabetes Mellitus (T1DM)
Status: Archived
Updated: 1/1/1970
Children's Mercy Hospital
mi
from
Kansas City, MO
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Tupelo, MS
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Cardiology Associates of N. Mississippi
mi
from
Tupelo, MS
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Little Rock, AK
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Arkansas Heart Hospital
mi
from
Little Rock, AK
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Phoenix, AZ
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Banner Good Samaritan Hospital
mi
from
Phoenix, AZ
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Tucson, AZ
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Tucson Medical Center
mi
from
Tucson, AZ
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Beverly Hills, CA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
ACT / CVRI & Cedar Sinai Medical Center
mi
from
Beverly Hills, CA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Washington,
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Washington Hospital
mi
from
Washington,
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Bradenton, FL
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Bradenton Cardiology Center
mi
from
Bradenton, FL
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Jacksonville, FL
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
First Coast Cardiovascular Institute
mi
from
Jacksonville, FL
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Miami Beach, FL
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Mount Sinai Comprehensive Cancer Center at Mount Sinai Medical Center
mi
from
Miami Beach, FL
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Fishers, IN
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Clarian North / Heart Partners
mi
from
Fishers, IN
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Munster, IN
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Cardiovascular Research of Northwest Indiana, LLC
mi
from
Munster, IN
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Hutchinson, KA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Hutchinson Clinic
mi
from
Hutchinson, KA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Bossier City, LA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Willis Knighton Bossier Medical Center
mi
from
Bossier City, LA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Houma, LA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Terrebonne General Hospital
mi
from
Houma, LA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Lafayette, LA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Cardiovascular Institute of the South
mi
from
Lafayette, LA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Opelousas, LA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Opelousas General Health System
mi
from
Opelousas, LA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Slidell, LA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Louisiana Heart Center
mi
from
Slidell, LA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Portland, ME
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Maine Children's Medical Center
mi
from
Portland, ME
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Olney, MD
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Montgomery General Hospital
mi
from
Olney, MD
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Chestnut Hill, MA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Boston, MA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Brighton, MA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Caritas St. Elizabeth Medical Center
mi
from
Brighton, MA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Wyoming, MI
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Metro Health Hospital
mi
from
Wyoming, MI
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Hattiesburg, MS
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Hattiesburg Clinic
mi
from
Hattiesburg, MS
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Browns Mills, NJ
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Deborah Heart
mi
from
Browns Mills, NJ
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Charlotte, NC
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Hunter-Hopkins Center, PA
mi
from
Charlotte, NC
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
New Brunswick, NJ
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
University of Medicine and Dentistry - Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Liverpool, NY
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Sjh Cardiology Associates
mi
from
Liverpool, NY
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Lenexa, KA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Lenexa Clinical Site 127
mi
from
Lenexa, KA
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
New York, NY
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
New York University Langone Medical Center
mi
from
New York, NY
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Winston-Salem, NC
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
Forsyth Medical Center
mi
from
Winston-Salem, NC
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Cincinnati, OH
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
mi
from
Cincinnatti, OH
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
Status: Archived
Updated: 1/1/1970
University Hospital
mi
from
Cincinnatti, OH